Metrics as of 10/16/2026, 08:31 AM (Berlin time), refresh in progress.
Alvotech Stock
Alvotech
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Luxembourg
- CEO
- Lisa Graver
- Employees
- 1,279
- Market cap
- $1.9 B
- IPO
- 16/06/2022
Alvotech is a healthcare company dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Established in 2013, the company maintains its primary corporate headquarters in Reykjavik, Iceland. Operating within the Drug Manufacturers - Specialty & Generic industry, its product offerings span…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Alvotech stock: price history
1D
+2.7%
1W
-6.3%
1M
+5.8%
6M
+46.7%
YTD
+3.5%
1Y
-40.9%
2Y
-57.5%
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~34% stronger price swings than usual
Ask the agents about Alvotech
Analyst assessment of Alvotech
PRICE TARGET LOW
US$8.00
CONSENSUS
US$8.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$8.00
0
STRONG BUY
3
BUY
2
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 16/09/2026
Alvotech stock metrics
P/E
-9.09
P/B
-9.9
EV/EBITDA
490.39
RETURN ON EQUITY
34.9%
NET MARGIN
-63.2%
DEBT/EQUITY
-7.58
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
30.5%
FLOAT SHARES
108,890,622
AVG. DAILY VOLUME (30D)
1,176,978
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.7%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Alvotech stock
What does Alvotech do?
Alvotech is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Luxembourg.
The CEO is Lisa Graver, the company employs around 1,279 people.
The IPO was on 16/06/2022; the stock trades on NASDAQ under the ticker ALVO.
What do analysts say about Alvotech stock?
5 analysts rate the stock, the consensus is Buy (as of 16/09/2026).
The average price target is US$8.00, ranging from US$8.00 to US$8.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does Alvotech report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 34% stronger than usual.
Does Alvotech pay a dividend?
No, Alvotech currently does not pay a dividend.
Which stocks are comparable to Alvotech?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Alvotech stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alvotech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.